Biofrontera Inc. Warrants (BFRIW)
Official siteDRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Last updated: Nov 02, 2026 at 4:00 PM ET
Earnings
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 90.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 19.5, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about BFRIW
News
No news available
Company news will appear here when available
BFRIW Profitability: Margins, ROIC and FCF
Biofrontera Inc. Warrants (BFRIW) has an operating margin of -4.4% and a net margin of -13.8%.
- Operating margin
- -4.4%
- Net margin
- -13.8%
- ROE
- -988.0%
Biofrontera Inc. Warrants Competitors
The companies most similar to Biofrontera Inc. Warrants (BFRIW) include Azitra, Dermata Therapeutics and Arcutis Biotherapeutics.
Sector: Healthcare
BFRIW Bull Case vs Bear Case
Bull case
- BFRIW grew quarterly revenue 32.9% year over year.
Bear case
- BFRIW has a -13.8% net profit margin.
Updated Aug 15, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About BFRIW
Does BFRIW pay dividends?
Biofrontera Inc. Warrants (BFRIW) does not currently pay a regular dividend.
BFRIW pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.